Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

PPD Opens Vaccine Research Center in Taizhou

publication date: Apr 27, 2010
PPD, Inc. has opened a vaccine clinical research center in China Medical City located in Taizhou. PPD will use to center to provide clinical monitoring services for multinational and local companies that are seeking approval for new vaccines in China. The new facility adds to PPD’s presence in China. In November of last year, PPD bought two China-based CROs, Excel PharmaStudies and BioDuro LLC, which began the major consolidation of CROs in China. More details...

Stock Symbol: (NSDQ: PPDI)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital